Myofascial Pain Syndrome and Dextrose Prolotherapy

Last updated: July 15, 2021
Sponsor: Mustafa Kemal University
Overall Status: Active - Recruiting

Phase

4

Condition

Fibromyalgia

Somatoform And Dissociative Disorders

Mood Disorders

Treatment

N/A

Clinical Study ID

NCT04941118
MustafaKUPMR-MPS
  • Ages 20-50
  • Female

Study Summary

Myofascial pain syndrome is characterized by the presence of hypersensitive points called trigger points that cause pain, tenderness, spasm, stiffness, limitation of movement, weakness, taut band within the muscle, and pain reflected by pressing in a muscle group or a single muscle.

Prolotherapy is a regenerative treatment method in the treatment of chronic musculoskeletal pain, in which an irritating solution is injected, often hypertonic dextrose, into painful ligament and tendon attachments and adjacent joint spaces.

In this study, it was aimed to examine the effect of prolotherapy application on pain, neck range of motion and neck disability in women with myofascial pain syndrome.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • 60 women aged 20-50 years with a diagnosis of myofascial pain syndrome

Exclusion

Exclusion Criteria:

  • Cervical radiculopathy, cervical degeneration, neck surgery or trauma in the lastyear, injection history for myofascial pain syndrome in the last 6 months, cognitiveimpairment and fibromyalgia, rheumatoid arthritis, hypothyroidism, diabetes mellitus

Study Design

Total Participants: 60
Study Start date:
July 15, 2021
Estimated Completion Date:
December 31, 2021

Connect with a study center

  • Hatay Mustafa Kemal University, Tayfur Ata Sökmen Faculty of Medicine

    Hatay, 31060
    Turkey

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.